Mr Poonawalla’s perspective on vaccine production and distribution is particularly pertinent, given that the Serum Institute is tasked with producing vaccine doses for much of the developing world.
As part of its agreement with AstraZeneca, the company will aim to produce vaccine doses that cost about $3 for 68 countries and under its agreement with Novavax, for 92 countries.predicted it would take four to five years before the pandemic was under control, adding that a vaccine “seems for now the best way out” but it was no silver bullet. Other important factors are containment measures and virus mutations which could make a vaccine ineffective.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: